Medical Center Medconsult Burgas EOOD

The Medical Center Medconsult Burgas EOOD conducts focused studies on Cardiovascular Diseases, aiming to test innovative treatments that improve heart health and reduce serious complications.

• Evaluation of cardiac structure and function
• Prevention of stroke and systemic embolism
• Assessment of bleeding risk
• Use of advanced imaging techniques

With a team of five investigators, the site advances knowledge in heart disease management for patients across Bulgaria and Europe.

Research at the center explores new approaches for patients with Atrial Fibrillation, especially those unsuitable for standard oral anticoagulants.

• Reducing risk of ischemic stroke
• Minimizing systemic embolism
• Evaluating safety regarding major bleeding
• Investigating alternative anticoagulation strategies

These studies seek to provide safer options and enhance long‑term outcomes for individuals living with AF.

The facility is evaluating novel therapy for chronic advanced heart failure with reduced ejection fraction (HFrEF), focusing on cardiac remodeling and functional improvement.

• Improving left‑ventricular ejection fraction
• Reducing heart size and wall stress
• Enhancing patients’ quality of life
• Monitoring changes via echocardiography

Findings aim to broaden treatment choices for patients struggling with severe heart failure.